Osmotic Diuresis Latest Advances

Find the Latest Research About Osmotic Diuresis

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1376 publications

SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications.

SGLT2 Inhibitors in the Modern Cardiology Era: Mechanisms, Outcomes, and Clinical Applications.

Journal: Cardiology in review

Published: August 03, 2026

Physiology of Kidney Glucose Transport and Mechanisms of Kidney Protection by SGLT2 Inhibitors.

Physiology of Kidney Glucose Transport and Mechanisms of Kidney Protection by SGLT2 Inhibitors.

Journal: Handbook of experimental pharmacology

Published: July 16, 2026

Early SGLT2 Inhibition in Acute Heart Failure: When More Urine Does Not Necessarily Mean Better Decongestion.

Early SGLT2 Inhibition in Acute Heart Failure: When More Urine Does Not Necessarily Mean Better Decongestion.

Journal: European journal of heart failure

Published: June 27, 2026

Allitol Exerts Distinct Osmotic Actions in Vivo: Intravenous Diuresis and Oral Gastrointestinal Water Retention.

Allitol Exerts Distinct Osmotic Actions in Vivo: Intravenous Diuresis and Oral Gastrointestinal Water Retention.

Journal: Biological & pharmaceutical bulletin

Published: June 17, 2026

SGLT-2 Inhibitors for Ascites Management in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Available Evidence.

SGLT-2 Inhibitors for Ascites Management in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Available Evidence.

Journal: International journal of hepatology

Published: April 30, 2026

Cardiorenal Hemodynamic Effects of SGLT2 Inhibitors Across Heart Failure Phenotypes: A Structured Narrative Review.

Cardiorenal Hemodynamic Effects of SGLT2 Inhibitors Across Heart Failure Phenotypes: A Structured Narrative Review.

Journal: Cardiovascular & hematological disorders drug targets

Published: March 16, 2026

Sodium-Glucose Cotransporter-2 Inhibitors Across the Glycemic Spectrum: Cardiovascular and Renal Outcomes With Mechanistic Insights.

Sodium-Glucose Cotransporter-2 Inhibitors Across the Glycemic Spectrum: Cardiovascular and Renal Outcomes With Mechanistic Insights.

Journal: Cureus

Published: March 12, 2026

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Conditions Beyond Heart Failure and Chronic Kidney Disease: Emerging Evidence, Mechanisms, and Practical Considerations.

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Non-diabetic Conditions Beyond Heart Failure and Chronic Kidney Disease: Emerging Evidence, Mechanisms, and Practical Considerations.

Journal: Cureus

Published: March 05, 2026

SGLT2 Inhibitors as a Novel Therapeutic Strategy in SIADH-Induced Hyponatraemia: Emerging Evidence and Clinical Implications.

SGLT2 Inhibitors as a Novel Therapeutic Strategy in SIADH-Induced Hyponatraemia: Emerging Evidence and Clinical Implications.

Journal: Journal of clinical medicine

Published: February 17, 2026

Autonomic dysreflexia: the concealed killer behind recurrent cerebral hemorrhage in spinal cord injury-a case report with management insights.

Autonomic dysreflexia: the concealed killer behind recurrent cerebral hemorrhage in spinal cord injury-a case report with management insights.

Journal: Frontiers in neuroscience

Published: January 30, 2026

Drug-induced hyponatremia associated with sodium-glucose cotransporter 2 inhibitors, immune checkpoint inhibitors, and targeted anticancer agents.

Drug-induced hyponatremia associated with sodium-glucose cotransporter 2 inhibitors, immune checkpoint inhibitors, and targeted anticancer agents.

Journal: Polish archives of internal medicine

Published: January 29, 2026

Efficacy and Risks of Dextrose Infusion to Prevent Postoperative Nausea: a Narrative Review.

Efficacy and Risks of Dextrose Infusion to Prevent Postoperative Nausea: a Narrative Review.

Journal: Advances in therapy

Published: January 28, 2026

Showing 1-12 of 1,376

Last Updated: 09/26/2026